LA

(redirected from Antiphospholipid antibody)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
Related to Antiphospholipid antibody: Antiphospholipid antibody syndrome

LA

The two-character ISO 3166 country code for LAO PEOPLE'S DEMOCRATIC REPUBLIC.

LA

1. ISO 3166-1 alpha-2 code for the Lao People's Democratic Republic. This is the code used in international transactions to and from Laotian bank accounts.

2. ISO 3166-2 geocode for Laos. This is used as an international standard for shipping to Laos. Each Laotian subdivision has its own code with the prefix "LA." For example, the code for the Province of Attapu is ISO 3166-2:LA-AT.
References in periodicals archive ?
International consensus statement on preliminary criteria for the classification of antiphospholipid antibody syndrome is as follows.
Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
Kawakami T, Yamazaki M, Mizoguchi M, Soma High titer of serum antiphospholipid antibody levels in adult Henoch-Schonlein purpura and cutaneous leukocytoclastic angiitis.
On the other hand, trials of women with antiphospholipid antibody syndrome have shown that pregnancy outcomes are improved with the use of aspirin plus heparin.
Data Source: A study of 333 pregnancies in women with low-activity systemic lupus erythematosus as part of the PROMISSE (Predictors of Pregnancy Outcome: Biomarkers in Antiphospholipid Antibody Syndrome and Systemic Lupus Erythematosus) study.
Antiphospholipid antibody syndrome is a heterogeneous syndrome, both clinically and in the laboratory.
Neurological aspects of antiphospholipid antibody syndrome.
This review addresses new clinical issues (revealed at the 2006 Sydney update of the 1999 Sapporo Classification criteria; cardiac, renal, and multiple sclerosis-like disease; catastrophic syndrome), mechanisms of action of antiphospholipid antibody (very likely complement mediated), current therapies (moderate dose warfarin recommended for prophylaxis, aspirin not recommended for primary prophylaxis), and potential new therapies.
Laboratory testing used for diagnosing APS includes coagulation assays for the detection of lupus anticoagulant (LA) and enzyme-linked immunosorbent assay (ELISA) for antiphospholipid antibody (APL) detection.
KEY MESSAGE: Cerebral venous sinus thrombosis is associated with hypercoaguable states and a number of immune-mediated conditions but its association with antiphospholipid antibody alone is rare.